Suspension of trading
Quotes Cerevel Therapeutics Holdings, Inc.
Stocks
CERE
US15678U1280
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
23:00:00 31/07/2024 +03
|
5-day change | 1st Jan Change | ||
| 44.96 USD | +0.74% |
|
-.--% | - |
Stock exchange
Nasdaq
CERE 44.96 $
+0.74%
679M
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 1 day | +0.74% | ||
| 3 years | +90.03% | ||
| 5 years | +27.76% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
8,191,474,701
Net sales ()
-
Number of employees
355
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
93.64 %
Free-Float capitalization (USD)
7,670,416,311
Indicators
Moving average 5 days
44.66
Moving average 100 days
41.9
Price spread / (MMA5)
-0.68%
Price spread / (MMA100)
-6.81%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.74% | -.--% | -.--% | +90.03% | 8.19B | ||
| -1.79% | -2.27% | +50.90% | +89.03% | 69.02B | ||
| -2.06% | -0.18% | +41.53% | +88.17% | 66.32B | ||
| -0.31% | +6.54% | -11.39% | +457.82% | 27.66B | ||
| -3.00% | -2.90% | +39.40% | +9.41% | 26.54B | ||
| +0.86% | +1.65% | +0.25% | -14.78% | 25.84B | ||
| -1.46% | +0.42% | +24.07% | -18.70% | 20.4B | ||
| -2.96% | -15.21% | +210.71% | +370.84% | 17.63B | ||
| -1.49% | -4.88% | -0.41% | +530.26% | 15.15B | ||
| -0.20% | +8.37% | +57.87% | +159.50% | 14.65B | ||
| Average | -1.17% | -0.31% | +41.29% | +176.16% | 29.14B | |
| Weighted average by Cap. | -1.47% | -0.33% | +41.36% | +143.40% |
Historical Quotes: Cerevel Therapeutics Holdings, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 19.59 | 44.99 | |
| 5 years | 19.59 | 46.16 | |
| 10 years | 9 | 46.16 |
Monthly variations
Annual variations
| 2024 | +6.04% | ||
| 2023 | +34.43% | ||
| 2022 | -2.71% | ||
| 2021 | +95.54% | ||
| 2020 | +39.33% |
- Stock Market
- Stocks
- CERE Stock
- Quotes Cerevel Therapeutics Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
















